Literature DB >> 16982466

Four primary malignancies successively occurred in a BRCA2 mutation carrier: a case report.

A Fruscalzo1, G Damante, A Calcagno, C Di Loreto, D Marchesoni.   

Abstract

Carriers of BRCA2 germline mutation have a significantly increased lifetime risk of breast and ovarian cancer compared to non carriers. Several other carcinomas seem to be associated with BRCA2 mutations: pancreas, prostate, larynx, gallbladder, bile duct cancer, and malignant melanoma. We described a case of a 67-year-old BRCA2 mutation carrier of Caucasian, non-Jewish, ethnic origin who successively developed 4 primary malignancies in 30 months: breast ductal carcinoma, chronic lymphatic leukemia, ovarian serous papillary carcinoma, and endocervical adenocarcinoma. This is the first case of 4 primary malignancies in a BRCA mutation carrier, also occurred in such a short observation period. Chronic lymphatic leukemia and endocervical adenocarcinoma have not been yet associated to BRCA2 germline mutation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982466     DOI: 10.1080/07357900600894872

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  3 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study.

Authors:  Javaid Iqbal; Andre Nussenzweig; Jan Lubinski; Tomasz Byrski; Andrea Eisen; Louise Bordeleau; Nadine M Tung; Siranoush Manoukian; Catherine M Phelan; Ping Sun; Steven A Narod
Journal:  Br J Cancer       Date:  2016-03-17       Impact factor: 7.640

3.  Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2021-04-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.